Chemical Supplier

21 October 2025 Press Release

Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a promising broad-spectrum coronavirus antiviral pre-clinical candidate. Enamine’s chemistry platform delivered over 2,000 new compounds during the early stages of the programme that resulted in the discovery of pre-clinical candidate ASAP-0017445. The candidate is designed to be a direct-to-generic, globally accessible treatment ready for future coronavirus pandemics.
23 September 2025 Press Release

Enamine joins forces with the ICR to expand fragment-based drug discovery with fluorinated compound libraries

Enamine Ltd., a leading global provider of screening compounds, chemical building blocks, and drug discovery services, and The Institute of Cancer Research, London, have announced a new research collaboration aimed at broadening the tools available for Fragment-based Drug Discovery (FBDD).
18 September 2025 Press Release

Enamine joins the CACHE Governing Board

We are pleased to announce that Enamine has joined the CACHE (Critical Assessment of Computational Hit-finding Experiments) Governing Board. Enamine has already played a central role in CACHE, serving as the primary supplier of compounds for the challenges since the very beginning.

Upcoming events

Please leave your request for any product you wish. We will be happy to search it for you in our databases or offer its custom synthesis